心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2017 EACVI临床实践建议：心脏超声造影检查

2017-09-12 欧洲协会心血管影像协会 Eur Heart J Cardiovasc Imaging. 2017 Sep 12.

心脏超声造影检查

2017年9月，欧洲协会心血管影像协会(EACVI)发布了心脏超声造影检查建议，心脏超声造影检查广泛应用于心脏病学科，本文主要针对临床脏超声造影检查的相关内容提出循证指导建议，内容包括造影剂，对比成像检查，超声心动图造影剂等。

中文标题：

2017 EACVI临床实践建议：心脏超声造影检查

英文标题：

Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017.

发布机构：

欧洲协会心血管影像协会

发布日期：

2017-09-12

简要介绍：

2017年9月，欧洲协会心血管影像协会(EACVI)发布了心脏超声造影检查建议，心脏超声造影检查广泛应用于心脏病学科，本文主要针对临床脏超声造影检查的相关内容提出循证指导建议，内容包括造影剂，对比成像检查，超声心动图造影剂等。

 

拓展指南：与心脏相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017 EACVI临床实践建议：心脏超声造影检查)] GetToolGuiderByIdResponse(projectId=1, id=a53e91c00150a62e, title=2017 EACVI临床实践建议：心脏超声造影检查, enTitle=Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017., guiderFrom=Eur Heart J Cardiovasc Imaging. 2017 Sep 12., authorId=null, author=, summary=2017年9月，欧洲协会心血管影像协会(EACVI)发布了心脏超声造影检查建议，心脏超声造影检查广泛应用于心脏病学科，本文主要针对临床脏超声造影检查的相关内容提出循证指导建议，内容包括造影剂，对比成像检查，超声心动图造影剂等。 , cover=, journalId=null, articlesId=null, associationId=1080, associationName=欧洲协会心血管影像协会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Sep 12 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>2017年9月，欧洲协会心血管影像协会(EACVI)发布了心脏超声造影检查建议，心脏超声造影检查广泛应用于心脏病学科，本文主要针对临床脏超声造影检查的相关内容提出循证指导建议，内容包括造影剂，对比成像检查，超声心动图造影剂等。 </P> <P> </P>拓展指南：<strong>与<font color=red>心脏</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=8f4531c001a91301" title="2015年欧洲心脏病学会关于感染性心内膜炎并发症治疗的指南解读" target=_blank>2015年欧洲心脏病学会关于感染性心内膜炎并发症治疗的指南解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7634b1c001ae62b5" title="冠心病血运重建后心脏性猝死的预防" target=_blank>冠心病血运重建后心脏性猝死的预防</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=bd26e1c001a3924f" title="【专题】先天性心脏病的防控，看看权威指南怎么建议" target=_blank>【专题】先天性心脏病的防控，看看权威指南怎么建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=0ab0e1c001a389db" title="新生儿危重先天性心脏病术前评估中国专家共识（草案）" target=_blank>新生儿危重先天性心脏病术前评估中国专家共识（草案）</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=1253e1c001a38ea1" title="2016年欧洲心脏病学会心房颤动管理指南（节选）（二）" target=_blank>2016年欧洲心脏病学会心房颤动管理指南（节选）（二）</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E8%84%8F" target=_blank>有关心脏更多指南</a></ul>, tagList=[TagDto(tagId=60434, tagName=心脏超声造影检查)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6553, appHits=331, showAppHits=0, pcHits=4855, showPcHits=1954, likes=178, shares=6, comments=4, approvalStatus=1, publishedTime=Sat Oct 07 19:12:28 CST 2017, publishedTimeString=2017-09-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 07 19:12:28 CST 2017, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 00:28:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 EACVI临床实践建议：心脏超声造影检查)])
2017 EACVI临床实践建议：心脏超声造影检查
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=801620, encodeId=75ef801620c8, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72735182434, createdName=奥利给🤗🤗, createdTime=Tue Jul 07 15:47:49 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252908, encodeId=7450252908d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Oct 14 21:24:09 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251697, encodeId=75b425169e98, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Oct 10 11:08:08 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251505, encodeId=637e2515054d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4mzqK7XHyH86ToibWNdzamnZozW6yiceXFib4QHq1lCOia34v7bgwXUIH1Rdnoqia2y6ibLX156v1xmicZw/0, createdBy=15891613430, createdName=xuexin53, createdTime=Mon Oct 09 11:31:43 CST 2017, time=2017-10-09, status=1, ipAttribution=)]
    2020-07-07 奥利给🤗🤗

    学习到了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=801620, encodeId=75ef801620c8, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72735182434, createdName=奥利给🤗🤗, createdTime=Tue Jul 07 15:47:49 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252908, encodeId=7450252908d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Oct 14 21:24:09 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251697, encodeId=75b425169e98, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Oct 10 11:08:08 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251505, encodeId=637e2515054d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4mzqK7XHyH86ToibWNdzamnZozW6yiceXFib4QHq1lCOia34v7bgwXUIH1Rdnoqia2y6ibLX156v1xmicZw/0, createdBy=15891613430, createdName=xuexin53, createdTime=Mon Oct 09 11:31:43 CST 2017, time=2017-10-09, status=1, ipAttribution=)]
    2017-10-14 有备才能无患

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=801620, encodeId=75ef801620c8, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72735182434, createdName=奥利给🤗🤗, createdTime=Tue Jul 07 15:47:49 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252908, encodeId=7450252908d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Oct 14 21:24:09 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251697, encodeId=75b425169e98, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Oct 10 11:08:08 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251505, encodeId=637e2515054d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4mzqK7XHyH86ToibWNdzamnZozW6yiceXFib4QHq1lCOia34v7bgwXUIH1Rdnoqia2y6ibLX156v1xmicZw/0, createdBy=15891613430, createdName=xuexin53, createdTime=Mon Oct 09 11:31:43 CST 2017, time=2017-10-09, status=1, ipAttribution=)]
    2017-10-10 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=801620, encodeId=75ef801620c8, content=学习到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72735182434, createdName=奥利给🤗🤗, createdTime=Tue Jul 07 15:47:49 CST 2020, time=2020-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252908, encodeId=7450252908d7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Oct 14 21:24:09 CST 2017, time=2017-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251697, encodeId=75b425169e98, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Tue Oct 10 11:08:08 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251505, encodeId=637e2515054d, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4mzqK7XHyH86ToibWNdzamnZozW6yiceXFib4QHq1lCOia34v7bgwXUIH1Rdnoqia2y6ibLX156v1xmicZw/0, createdBy=15891613430, createdName=xuexin53, createdTime=Mon Oct 09 11:31:43 CST 2017, time=2017-10-09, status=1, ipAttribution=)]
    2017-10-09 xuexin53

    学习

    0